Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

RMPIA
By

Bret Jensen

 | Apr 23, 2018 | 10:00 AM EDT
I think M&A activity will pick up markedly going forward across the industry.
RMPIA
By

Bret Jensen

 | Apr 20, 2018 | 1:30 PM EDT
Secondary offerings create buying opportunities.
By

Bret Jensen

 | Apr 18, 2018 | 1:00 PM EDT
A look at three names to consider in the biotech and biopharma space.
RMPIA
By

Bret Jensen

 | Apr 16, 2018 | 2:26 PM EDT
Data and industry conferences will likely be catalysts for shares in the space.
RMPIA
By

Bret Jensen

 | Apr 15, 2018 | 10:00 AM EDT
Here are some smaller names I have my eye on as the season heats up.
RMPIA
By

Bret Jensen

 | Apr 13, 2018 | 2:30 PM EDT
Here are some smaller names I have my eye on.
RMPIA
By

Bret Jensen

 | Apr 11, 2018 | 1:00 PM EDT
Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.
RMPIA
By

Bret Jensen

 | Apr 11, 2018 | 10:28 AM EDT
Now that M&A is picking up in the sector, here's what to watch as earnings releases begin to hit.
RMPIA
By

Bret Jensen

 | Apr 9, 2018 | 11:40 AM EDT
A look at possible second-quarter M&A activity in the biotech sector.
By

Bret Jensen

 | Apr 4, 2018 | 11:42 AM EDT
Talk of intensifying trade war is creating some bargains for investors.

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.